Table 2.
Areas | Total, n |
Amoxicillin | Clarithromycin | Metronidazole | Levofloxacin | Minocycline | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
||
Khentii | 90 | 12 | 13.3 (7.5–21.5) |
22 | 24.4 (16.5–34) |
75 | 83.3 (74.6–89.9) |
42 | 46.7 (36.6–56.9) |
0 | 0.0 |
Khuvsgul | 35 | 7 | 20.0 (9.4–35.3) |
6 | 17.1 (7.5–32) |
29 | 82.9 (68–92.5) |
14 | 40.0 (25.1–56.5) |
0 | 0.0 |
Ulaanbaatar | 124 | 11 | 8.9 (4.8–14.8) |
42 | 33.9 (26–42.5) |
91 | 73.4 (65.1–80.6) |
47 | 37.9 (29.7–46.6) |
1 | 0.8 (0.1–3.7) |
Umnugovi | 84 | 6 | 7.1 (3.0–14.1) |
24 | 28.6 (19.8–38.8) |
68 | 81.0 (71.6–88.2) |
35 | 41.7 (31.6–52.3) |
0 | 0.0 |
Uvs | 28 | 7 |
25.0 * (11.9–42.9) |
14 |
50.0 * (32.2–67.8) |
21 | 75.0 (57.1–88.1) |
11 | 39.3 (23–57.7) |
0 | 0.0 |
* p = 0.043 | * p = 0.034 | NS | NS | NS |
NS; not significant.